Multiple myeloma trials in Estonia

3 trials · From ClinicalTrials.gov, checked 11 November 2026. Ask the study team whether a trial fits you.

• Phase 2Not yet taking people in Estonia
  Teclistamab in Combination With Pomalidomide Administered in Alternative Fashion in Participants With Relapsed or Refractory Multiple Myeloma.

  Where

  Tallinn, Tartu Linn

  Age

  18 years and over

  People

  50 worldwide

  Run by

  Odense University Hospital

  See details and how to joinNCT07757412 · EU 2025-522114-23-00
• Phase 3Taking people
  A Study to Learn How Safe and How Well Linvoseltamab Works Compared to Standard Treatment in Adult Patients With Multiple Myeloma Who Are Not Eligible for Transplant

  Where

  Tallinn, Tartu Linn

  Age

  18 years and over

  People

  1,000 worldwide

  Run by

  European Myeloma Network B.V.

  See details and how to joinNCT06932562 · EU 2024-519827-16-00
• Phase 2Taking people
  Bispecific T-cell Redirectors as Part of First Line Treatment in Transplant Eligible Multiple Myeloma Patients

  Where

  Tallinn

  Age

  18 years to 70 years

  People

  50 worldwide

  Run by

  North Estonia Medical Centre

  See details and how to joinNCT06505369